Here are relevant reports on : biotechnology-reagent-market

• Biorefinery Market by Technology (Industrial Biotechnology, Physico-Chemical, Thermochemical), Product (Energy, Material), Type (First Generation (Corn, Vegetable Oils, Sugarcane), Second Generation, Third Generation) and Region - Global Forecast to 2029

  The biorefinery market is projected to reach USD 314.62 billion by 2029, at a CAGR of 8.2% during the forecast period. Some of the major players in the biorefinery market are Chevron (US), ADM (US), Valero (US), Neste (Finland), and TotalEnergies (France) among others. The major strategies adopted by these players include new product launches, acquisitions, contracts, agreements, partnerships, joint ventures, collaborations, investments, and expansions.

  • Published: February 2025
  • Price: $ 4950
  • TOC Available:

• Agriculture Biotechnology Market (Agriculture-Themed Microarrays Lab-on-Chip Devices RNA Interference Assays, Agriculture-Derived Biofuels Chemicals Transgenic Seeds) - 2018 By Application & Geography

  • Published: June 2026
  • Price: $ 4950
  • TOC Available:

• Agriculture Biotechnology Market by Type of Organism (Plant, Animal, and Microbes), Type, Technology, Application, and Region - Global Forecast to 2030

  The agriculture biotechnology market is projected to grow from USD 92.19 billion in 2025 to USD 144.25 billion by 2030, at a CAGR of 9.4%. The report profiles key players operating in the global agriculture biotechnology market, including Bayer Crop Science, Corteva Agriscience, BASF SE, Syngenta AG, Zoetis Inc., Elanco Animal Health, Novonesis (Novozymes and Chr. Hansen), and Lallemand Plant Care, among others.

  • Published: October 2025
  • Price: $ 4950
  • TOC Available:

• Pipette Calibrators Market by Type (Devices, Software), Channel Type, Method (Gravimetry, Photometry), Application (Research (Drug Discovery), Clinical Diagnostics), End User (Pharmaceutical & Biotechnology), & Region - Global Forecast to 2029

  The global pipette calibrators market, valued at US$255 million in 2022, stood at US$286 million in 2023 and is projected to advance at a resilient CAGR of 6.5% from 2023 to 2028, culminating in a forecasted valuation of US$391 million by the end of the period. The growth in this market is attributed to the increasing need for pipettes in research facilities, and growing use of portable handheld calibration devices, and adoption of cloud-based calibration management. However, presence of alternative simple methods or techniques could restrain the growth of this market.

  • Published: February 2024
  • Price: $ 4950
  • TOC Available:

• Aptamers Market by Product Type (DNA, RNA, XNA), Technology (SELEX), Application (Therapeutics, Diagnostics, R&D), End Users (Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, CROs) - Global Forecast to 2026

  The global aptamers market growth is primed to transition from $151 million in 2021 to $342 million by 2026, showcasing a strong CAGR of 17.7%. Growth of the market is attributed to factors such as increase in number of clinical trials for development of aptamer-based therapeutics, increase in awareness about advantages of aptamers as compared to antibodies, rising investment in pharmaceutical R&D, and rising prevalence of chronic and rare diseases to increase the demand for aptamer-based therapeutics and diagnostics. Growth in the venture capital funding for research on aptamers and growing collaborations with research institutes and pharmaceutical companies are also expected to offer a wide range of growth opportunities to players in the market.

  • Published: November 2021
  • Price: $ 4950
  • TOC Available:

• HPC Data Management Market in Life Sciences By Products & Services (Data Analysis, Cloud Computing), Applications (NGS, Microscopy, Chromatography), End User (Pharmaceutical & Biotechnology, Hospitals) - Global Forecast to 2024

  The HPC Data Management Market in life sciences is projected to reach USD 41.1 billion by 2024, at a CAGR of 17.1%. The growth of this market is majorly driven by the growing demand for data storage and management solutions due to extensive amount of data generated through large number of research activities. However, the high cost of implementation and regulatory hurdles are major factors restraining the growth of this market.Dell Technologies Inc. (US), Advanced Micro Devices, Inc. (US), Cray, Inc. (US), Cisco Systems, Inc. (US), IBM Corporation (US), Intel Corporation (US), Lenovo Group Limited (China), Hewlett Packard Enterprise Company (US).

  • Published: April 2019
  • Price: $ 4950
  • TOC Available:

• PEGylated Proteins Market by Consumables (PEGylation Kits, Reagents), Services, Protein Type (mAbs, Interferons), Application (Cancer Treatment, Chronic Kidney Diseases), End-User (Pharmaceutical & Biotechnology Companies)- Global Forecast to 2021

  The global PEGylated proteins market size is projected to grow at a CAGR of 10.5%. The major drivers for the market include increase in R&D spending of pharmaceutical & biotechnology companies, growth in biologics sector, high prevalence of lifestyle disease, increasing focus on strategies to improve protein stability and circulating half-life. The rising opportunities in emerging markets and top-selling biologics drugs going off-patent in the near future will provide new growth opportunities for this market.

  • Published: November 2016
  • Price: $ 4950
  • TOC Available:

• CIP Chemicals Market by Chemistry, Process Type (Single-use Cleaning and Recirculated Cleaning), End-use Industry (Chemicals, Food & Beverage, Pharmaceutical & Biotechnology, Cosmetics, Textiles), and Region - Global Forecast to 2029

  The CIP chemicals market is expected to grow from USD 15.60 billion in 2024 to USD 24.00 billion by 2029, at a CAGR of 9.0% during the forecast period. To enable an in-depth understanding of the competitive landscape, the report includes the profiles of some of the top players in the CIP chemicals market. These are ALFA LAVAL (Sweden), BASF (Germany), Ecolab (US), Novozymes (Denmark), STERIS (US), Solvay (Belgium), KIC KRONES Internationale Cooperations-Gesellschaft mbH (Germany), Diversey, Inc (US), Chemtex Speciality Limited (India), and Keller & Bohacek GmbH & Co. KG (Germany).

  • Published: March 2025
  • Price: $ 4950
  • TOC Available:

• Protein Binding Assays Market by Technology (Equillibrium Dialysis, Ultrafiltration, Ultracentrifugation, Gel Filtration Chromatography), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organization) - Global Forecast to 2023

  The major players operating in the global protein binding assay market are Thermo Fisher (US), HTDialysis (US), Merck (US), GE Healthcare (US), and Absorption Systems (US). The global protein binding market is projected to reach USD 425.7 million in 2023 from USD 256.1 million in 2018, at a CAGR of 10.7%. The growing number of drug discovery activities, the minimizing drug discovery and development costs, and the increase in pharmaceutical R&D expenditure are driving the growth of this market. The key players in the global protein binding assays market are HTDialysis (US), Thermo Fisher Scientific (US), Merck (Germany), and Sovicell (Germany).

  • Published: August 2018
  • Price: $ 4950
  • TOC Available:

• North America Chromatography Resins Market by Technique (Ion Exchange (Cation and Anion), Affinity, Hydrophobic Interaction, Mixed Mode), Application (Pharmaceutical & Biotechnology), Type (Natural, Synthetic, Inorganic Media), and Country - Forecast to 2030

  North America Chromatography Resins Market

  • Published: May 2026
  • Price: $ 4950
  • TOC Available:

• FIRST
• PREVIOUS

Records 41 to 50 of 50